Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.94 Analyst target: $114.29 Upside: 2213.56%
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.